Literature DB >> 31667749

Management of Urinary Tract Infections in Direct to Consumer Telemedicine.

Radhika Rastogi1, Kathryn A Martinez2, Niyati Gupta2, Mark Rood3, Michael B Rothberg2.   

Abstract

BACKGROUND: Urinary tract infections (UTI) are a common reason for seeking care via direct to consumer (DTC) telemedicine, yet patterns of care, including antibiotic prescribing, have not been reported.
OBJECTIVE: To describe management of UTI in a large nationwide DTC telemedicine platform.
DESIGN: Cross-sectional observational study. PARTICIPANTS: Patients seeking care for or diagnosed with UTI via DTC telemedicine between July 2016 and July 2018. MAIN MEASURES: Patient measures included age, sex, geographic region, satisfaction with care, and patient-reported call reason. High-risk patients were defined as males, patients over 65 years, or those diagnosed with pyelonephritis. Physician measures included specialty and geographic region. Antibiotic prescription was assessed overall and by antibiotic type. Variation in antibiotic prescriptions was assessed by patient and physician factors, including geographic region of both parties. KEY
RESULTS: Of the 20,600 patients diagnosed with a UTI during the study period, 96% were female. Most (84%) stated their call reason was a UTI. Overall, 94% of UTI patients received an antibiotic; 56% got nitrofurantoin, 29% got trimethoprim-sulfamethoxazole, and 10% got a quinolone. Receipt of an antibiotic was associated with higher satisfaction with care (p < 0.001). While nitrofurantoin was the most common antibiotic for all physician regions, antibiotic type varied by physician region. Of the 6% of the study population defined as high risk, 69% received an antibiotic: 72% of males, 91% of women over 65, and 21% of patients diagnosed with pyelonephritis.
CONCLUSIONS: Management of UTI via DTC telemedicine appears to be appropriate for average-risk patients, and most are able to self-diagnose. Most patients received guideline-concordant care, but over half of high-risk patients received antibiotics. DTC telemedicine offers convenient, low-cost care that is generally appropriate. Efforts should be made to ensure high-risk patients get proper follow-up.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31667749      PMCID: PMC7080949          DOI: 10.1007/s11606-019-05415-7

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  19 in total

1.  The safety of telephone management of presumed cystitis in women.

Authors:  David R Vinson; Charles P Quesenberry
Journal:  Arch Intern Med       Date:  2004-05-10

2.  Effectiveness and safety of telemedical management in uncomplicated urinary tract infections.

Authors:  Eva Blozik; Carsten Sommer-Meyer; Manuela Cerezo; Jan von Overbeck
Journal:  J Telemed Telecare       Date:  2010-11-19       Impact factor: 6.184

3.  Evaluation of suspected urinary tract infection in ambulatory women: a cost-utility analysis of office-based strategies.

Authors:  H C Barry; M H Ebell; J Hickner
Journal:  J Fam Pract       Date:  1997-01       Impact factor: 0.493

4.  Patterns of Use and Correlates of Patient Satisfaction with a Large Nationwide Direct to Consumer Telemedicine Service.

Authors:  Kathryn A Martinez; Mark Rood; Nikhyl Jhangiani; Lei Kou; Susannah Rose; Adrienne Boissy; Michael B Rothberg
Journal:  J Gen Intern Med       Date:  2018-08-15       Impact factor: 5.128

5.  Recurrent urinary tract infections in healthy and nonpregnant women.

Authors:  Matthew Glover; Cristiano G Moreira; Vanessa Sperandio; Philippe Zimmern
Journal:  Urol Sci       Date:  2014-03

6.  The convenience revolution for treatment of low-acuity conditions.

Authors:  Ateev Mehrotra
Journal:  JAMA       Date:  2013-07-03       Impact factor: 56.272

7.  A randomized controlled trial of telephone management of suspected urinary tract infections in women.

Authors:  H C Barry; J Hickner; M H Ebell; T Ettenhofer
Journal:  J Fam Pract       Date:  2001-07       Impact factor: 0.493

8.  Management of urinary tract infection in general practice: a cost-effectiveness analysis.

Authors:  E A Fenwick; A H Briggs; C I Hawke
Journal:  Br J Gen Pract       Date:  2000-08       Impact factor: 5.386

9.  Urologic diseases in America project: trends in resource use for urinary tract infections in women.

Authors:  Tomas L Griebling
Journal:  J Urol       Date:  2005-04       Impact factor: 7.450

10.  All dysuria is local. A cost-effectiveness model for designing site-specific management algorithms.

Authors:  Michael B Rothberg; John B Wong
Journal:  J Gen Intern Med       Date:  2004-05       Impact factor: 5.128

View more
  5 in total

1.  Telehealth in Urology: A Systematic Review of the Literature. How Much Can Telemedicine Be Useful During and After the COVID-19 Pandemic?

Authors:  Giacomo Novara; Enrico Checcucci; Alessandro Crestani; Alberto Abrate; Francesco Esperto; Nicola Pavan; Cosimo De Nunzio; Antonio Galfano; Gianluca Giannarini; Andrea Gregori; Giovanni Liguori; Riccardo Bartoletti; Francesco Porpiglia; Roberto Mario Scarpa; Alchiede Simonato; Carlo Trombetta; Andrea Tubaro; Vincenzo Ficarra
Journal:  Eur Urol       Date:  2020-06-18       Impact factor: 20.096

2.  Use of Direct-to-Consumer Telemedicine to Access Mental Health Services.

Authors:  Jessica A Hohman; Kathryn A Martinez; Amit Anand; Mark Rood; Trejeeve Martyn; Susannah Rose; Michael B Rothberg
Journal:  J Gen Intern Med       Date:  2022-01-29       Impact factor: 6.473

3.  Home urinary tract infection testing: patient experience and satisfaction with polymerase chain reaction kit.

Authors:  Alexandra I Melnyk; Coralee Toal; Stephanie Glass Clark; Megan Bradley
Journal:  Int Urogynecol J       Date:  2022-08-09       Impact factor: 1.932

4.  Virtual Care and the Inverse Care Law: Implications for Policy, Practice, Research, Public and Patients.

Authors:  Hassane Alami; Pascale Lehoux; Sara E Shaw; Chrysanthi Papoutsi; Sarah Rybczynska-Bunt; Jean-Paul Fortin
Journal:  Int J Environ Res Public Health       Date:  2022-08-25       Impact factor: 4.614

5.  [Digital innovation in medicine: the COVID-19 pandemic as an accelerator of "digital health"].

Authors:  Jan-Niclas Mumm; Severin Rodler; Maja-Lena Mumm; Ricarda M Bauer; Christian G Stief
Journal:  J Urol Urogynakologie       Date:  2020-12-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.